C0M8N3 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifsjfcdbheatfojdqv4p4scbtuw2xox7i2adyreucm6ysi2yoytce/metadata.json
IPFS of structure file: 
bafybeidcsnqhvnvo3h43tszw275gttcdrudh627zb5ynstxu643s4x67fu/AF-C0M8N3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd27f4D98eE625C1f8E81f7ac0eF38f876f24543e
First NFT owner address (bech32): 
genesis16fl5mx8wvfwplr5p77kqauu0sahjg4p7w0r097
Current NFT ID #450409 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
450409
Accession (UniProt):
C0M8N3
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Streptococcus equi subsp. equi (strain 4047)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C0M8N3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C0M8N3|SYL_STRE4 Leucine--tRNA ligase OS=Streptococcus equi subsp. equi (strain 4047) OX=553482 GN=leuS PE=3 SV=1 MTFYNHKAIEPKWQAFWADNHTFKTGTDASKPKFYALDMFPYPSGAGLHVGHPEGYTATDILSRFKRAQGYNVLHPMGWDAFGLPAEQYAMDTGNDPAEFTAENIANFKRQINALGFSYDWDREINTTDPSYYKWTQWIFTKLYEKGLAYEAEVPVNWVEELGTAIANEEVLPDGTSERGGYPVVRKPMRQWMLKITAYAERLLADLEEVDWPESIKDMQRNWIGKSTGANVTFKVKDTDKDFTVFTTRPDTLFGATYAVLAPEHALVDSITTAEQAQAVAEYKRQASLKSDLARTDLAKEKTGVWTGAYAINPVNGKEMPIWIADYVLASYGTGAIMAVPAHDERDWAFAKQFNLEIIPVLEGGNVDEAAYTEDGIHINSDFLDGLDKACAIAKMVAWLEETGVGHEKVSYRLRDWLFSRQRYWGEPIPIIHWEDGTSTAVPEQDLPLVLPVTKDIRPSGTGESPLANLTDWLEVTREDGVKGRRETNTMPQWAGSSWYYLRYIDPHNDEQLADKDLLKQWLPVDIYIGGAEHAVLHLLYARFWHKVLYDLGVVPTKEPFQKLFNQGMILGTSYRDHRGALVATDKVDKRDGSFFHMETGEELEQAPAKMSKSLKNVVNPDDVVEQYGADTLRVYEMFMGPLDASIAWSEEGLEGARKFLDRVYRLITTKEIVAENSGALDKAYHETVKAVTEQIEGMKFNTAIAQLMIFVNAANKEDELYVAYAKGFVQLLAPFAPHLGEELWQILTASGQSISYVAWPTHDDSKLVENDVEIVVQIKGKVKAKLVVAKDLSREELEKVALAHDKIQAEIAGKEVAKVIVVPNKLVNIVVK